Reliable and gentler control of cellular activity with light: Researchers at the Cluster of Excellence Multiscale Bioimaging (MBExC) and the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ OT) of the University Medical Center Göttingen (UMG) have developed a light-sensitive protein that can restore vision and hearing and regulate the heart rhythm. The special feature: Even very small light doses are sufficient to operate this “molecular light switch”. This opens up new possibilities for the development of innovative therapies to treat blindness, deafness and cardiac arrhythmia. The results were published in the renowned journal “Nature Biomedical Engineering”.
You can find the press release here.
